The goals of Jonathan Finkelstein's research are to:

  • Promote judicious antibiotic use in primary care practice.
  • Measure trends in community antibiotic resistance among key pathogens.
  • Develop new research methods and infrastructure to measure and improve the quality of care for children.

His research has included a wide range of epidemiologic studies of disease burden in defined populations. He has also conducted cluster-randomized behavior change intervention trials for both providers and patients to improve asthma care and to promote more judicious antibiotic prescribing.  Currently, he leads a decade-long longitudinal study of antibiotic resistance in eight Massachusetts communities. 

Active Projects:

2010-2015 Conjugate vaccine impact on pneumococcal carriage, disease, and population genetics

NIH-NIAID 2 R01 AI066304-05
Principal Investigator

This research continues the examination of trends in pneumococcal colonizing and invasive disease isolates, will assess shifts in pneumococcal population structure by MLST, and use whole genome sequencing to identify potential genetic determinants associated with serotype switching and invasiveness.

2010-2015 Emerging trends in antimicrobial use and their impact on primary care for children

NIH-NICHD 1K24HD060786
Principal Investigator

This mid-career development award allows investigation of antibiotic use trends using data from 3 health plans, as well as conducting a parent survey regarding current views of antibiotic use among the general public. It also allows Dr. Finkelstein to focus additional effort on mentorship activities in his roles as a research fellowship director.

2013-2018 Research Training in Prevention and Care of Chronic Illness in Childhood

NICHD 1T32HD075727-01
Principal Investigator

This NRSA program supports training for researchers to study prevention and care delivery for children, particularly those with chronic conditions.  It will include research on childhood risk factors for disease; and methods to transform health systems to deliver more effective, coordinated care. The program will support trainee stipends and tuition at the Harvard School of Public Health, and other fellowship expenses.

2013-2018 Training in child health services research and implementation science     

AHRQ 2T32HS000063-20
Principal Investigator

This grant supports an NRSA post-doctoral fellowship program for health services researchers across pediatric subspecialties with a focus on training in implementation science. The program will support trainee stipends and tuition at the Harvard School of Public Health, and other fellowship expenses.


Jonathan Finkelstein received his MD from the University of Pennsylvania School of Medicine and his MPH from Harvard School of Public Health. He completed an internship, residency and fellowship at Boston Children's Hospital.  Dr. Finkelstein is the Vice Chair for Quality and Outcomes and holds the Donald M. Berwick Chair in Pediatric Quality and Outcomes at Boston Children’s Hospital.  He co-directs a training program for pediatric health services researchers and teaches extensively at Harvard Medical School.


Publications powered by Harvard Catalyst Profiles

  1. Measuring complications of serious pediatric emergencies using ICD-10. Health Serv Res. 2021 Apr; 56(2):225-234. View abstract
  2. Trends in Severe Pediatric Emergency Conditions in a National Cohort, 2008 to 2014. Pediatr Emerg Care. 2020 Nov; 36(11):e620-e621. View abstract
  3. Development of a rubric for assessing delayed diagnosis of appendicitis, diabetic ketoacidosis and sepsis. Diagnosis (Berl). 2020 Jun 25. View abstract
  4. Trends in Capability of Hospitals to Provide Definitive Acute Care for Children: 2008 to 2016. Pediatrics. 2020 01; 145(1). View abstract
  5. Accuracy of automated identification of delayed diagnosis of pediatric appendicitis and sepsis in the ED. Emerg Med J. 2019 Dec; 36(12):736-740. View abstract
  6. Complications of Serious Pediatric Conditions in the Emergency Department: Definitions, Prevalence, and Resource Utilization. J Pediatr. 2019 11; 214:103-112.e3. View abstract
  7. Telemedicine and Antibiotic Use: One Click Forward or Two Steps Back? Pediatrics. 2019 09; 144(3). View abstract
  8. Trends in Outpatient Antibiotic Use in 3 Health Plans. Pediatrics. 2019 01; 143(1). View abstract
  9. Authors' Response. Pediatrics. 2018 08; 142(2). View abstract
  10. Use of a National Database to Assess Pediatric Emergency Care Across United States Emergency Departments. Acad Emerg Med. 2018 12; 25(12):1355-1364. View abstract
  11. Timing and Location of Emergency Department Revisits. Pediatrics. 2018 05; 141(5). View abstract
  12. Cardiac Arrest Survival in Pediatric and General Emergency Departments. Pediatrics. 2018 02; 141(2). View abstract
  13. Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period. Pediatrics. 2017 Nov; 140(5). View abstract
  14. Preparation for Transition to Adult Care Among Medicaid-Insured Adolescents. Pediatrics. 2017 Jul; 140(1). View abstract
  15. Impact of an Individual Mandate and Other Health Reforms on Dependent Coverage for Adolescents and Young Adults. Health Serv Res. 2018 06; 53(3):1581-1599. View abstract
  16. Medication Reconciliation Failures in Children and Young Adults With Chronic Disease During Intensive and Intermediate Care. Pediatr Crit Care Med. 2017 Apr; 18(4):370-377. View abstract
  17. Discrepancies Between Prescribed and Actual Pediatric Home Parenteral Nutrition Solutions. Nutr Clin Pract. 2016 Oct; 31(5):654-8. View abstract
  18. Parent and Teen Engagement in Pediatric Health Services Research Training. Acad Pediatr. 2016 07; 16(5):496-498. View abstract
  19. Health Care Transition in Young Adults With Type 1 Diabetes: Perspectives of Adult Endocrinologists in the U.S. Diabetes Care. 2016 Feb; 39(2):190-7. View abstract
  20. Incidence of Urinary Tract Infection Among Siblings of Children With Vesicoureteral Reflux. Acad Pediatr. 2016 07; 16(5):489-495. View abstract
  21. Oversight on the borderline: Quality improvement and pragmatic research. Clin Trials. 2015 Oct; 12(5):457-66. View abstract
  22. Development and Validation of the Adolescent Assessment of Preparation for Transition: A Novel Patient Experience Measure. J Adolesc Health. 2015 Sep; 57(3):282-7. View abstract
  23. Prevalence of Parental Misconceptions About Antibiotic Use. Pediatrics. 2015 Aug; 136(2):221-31. View abstract
  24. Predictors of timing of transfer from pediatric- to adult-focused primary care. JAMA Pediatr. 2015 Jun; 169(6):e150951. View abstract
  25. Selective and genetic constraints on pneumococcal serotype switching. PLoS Genet. 2015 Mar; 11(3):e1005095. View abstract
  26. Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced. BMC Infect Dis. 2015 Feb 18; 15:68. View abstract
  27. Pulmonary support on day of life 30 is a strong predictor of increased 1 and 5-year morbidity in survivors of congenital diaphragmatic hernia. J Pediatr Surg. 2015 May; 50(5):849-55. View abstract
  28. Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis. Antimicrob Resist Infect Control. 2014; 3:16. View abstract
  29. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc. 2014 Jul-Aug; 21(4):602-6. View abstract
  30. Finding the role of health care in population health. JAMA. 2014 Feb 26; 311(8):797-8. View abstract
  31. Recent trends in outpatient antibiotic use in children. Pediatrics. 2014 Mar; 133(3):375-85. View abstract
  32. Leveraging text messaging and mobile technology to support pediatric obesity-related behavior change: a qualitative study using parent focus groups and interviews. J Med Internet Res. 2013 Dec 06; 15(12):e272. View abstract
  33. Health care transition in young adults with type 1 diabetes: barriers to timely establishment of adult diabetes care. Endocr Pract. 2013 Nov-Dec; 19(6):946-52. View abstract
  34. Childhood infections, antibiotics, and resistance: what are parents saying now? Clin Pediatr (Phila). 2014 Feb; 53(2):145-50. View abstract
  35. Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts. J Pediatric Infect Dis Soc. 2014 Mar; 3(1):23-32. View abstract
  36. Deceased-donor split-liver transplantation in adult recipients: is the learning curve over? J Am Coll Surg. 2013 Oct; 217(4):672-684.e1. View abstract
  37. Transition experiences and health care utilization among young adults with type 1 diabetes. Patient Prefer Adherence. 2013; 7:761-9. View abstract
  38. Deceased donor liver transplantation in infants and small children: are partial grafts riskier than whole organs? Liver Transpl. 2013 Jul; 19(7):721-9. View abstract
  39. Putting antibiotic prescribing for children into context. JAMA. 2013 Jun 12; 309(22):2388-9. View abstract
  40. Pulmonary support on day 30 as a predictor of morbidity and mortality in congenital diaphragmatic hernia. J Pediatr Surg. 2013 Jun; 48(6):1183-9. View abstract
  41. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet. 2013 Jun; 45(6):656-63. View abstract
  42. Evaluating the implementation of expert committee recommendations for obesity assessment. Clin Pediatr (Phila). 2013 Feb; 52(2):131-8. View abstract
  43. Trends in antibiotic use in Massachusetts children, 2000-2009. Pediatrics. 2012 Jul; 130(1):15-22. View abstract
  44. Health care transition in patients with type 1 diabetes: young adult experiences and relationship to glycemic control. Diabetes Care. 2012 Aug; 35(8):1716-22. View abstract
  45. Why do children with ADHD discontinue their medication? Clin Pediatr (Phila). 2012 Aug; 51(8):763-9. View abstract
  46. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis. 2012 May 15; 205(10):1589-92. View abstract
  47. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J. 2012 Mar; 31(3):249-54. View abstract
  48. Planning and incorporating public health preparedness into the medical curriculum. Am J Prev Med. 2011 Oct; 41(4 Suppl 3):S193-9. View abstract
  49. Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine. 2011 Nov 08; 29(48):8877-81. View abstract
  50. New approaches to estimating national rates of invasive pneumococcal disease. Am J Epidemiol. 2011 Jul 15; 174(2):234-42. View abstract
  51. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J. 2011 Apr; 30(4):302-8. View abstract
  52. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011 Apr 18; 29(18):3398-412. View abstract
  53. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011 Jan; 17(1):62-8. View abstract
  54. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine. 2010 Dec 16; 29(2):283-8. View abstract
  55. Preparing medical students for the continual improvement of health and health care: Abraham Flexner and the new "public interest". Acad Med. 2010 Sep; 85(9 Suppl):S56-65. View abstract
  56. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics. 2010 Jun; 2(2):80-4. View abstract
  57. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine. 2010 Jul 05; 28(30):4842-6. View abstract
  58. Medical education for a healthier population: reflections on the Flexner Report from a public health perspective. Acad Med. 2010 Feb; 85(2):211-9. View abstract
  59. Comparing medical homes for children with ADHD and asthma. Acad Pediatr. 2010 Jan-Feb; 10(1):56-63. View abstract
  60. Research during pediatric residency training: outcome of a senior resident block rotation. Pediatrics. 2009 Oct; 124(4):1126-34. View abstract
  61. Early child care and adiposity at ages 1 and 3 years. Pediatrics. 2009 Aug; 124(2):555-62. View abstract
  62. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis. 2009 Jul 11; 9:110. View abstract
  63. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009 Jul; 124(1):e1-11. View abstract
  64. Reducing the prescribing of heavily marketed medications: a randomized controlled trial. J Gen Intern Med. 2009 Aug; 24(8):897-903. View abstract
  65. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis. 2009 Feb 01; 199(3):320-5. View abstract
  66. Impact of pneumococcal vaccine on 6C carriage. Journal of Infectious Diseases. 2008; In Press. View abstract
  67. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008 Dec; 135(6):1907-13. View abstract
  68. Does connection to primary care matter for children with attention-deficit/hyperactivity disorder? Pediatrics. 2008 Aug; 122(2):368-74. View abstract
  69. Does connection to primary care matter for children with ADHD?. Pediatrics. 2008; 122:368-374. View abstract
  70. Are performance measures based on automated medical records valid for physician/practice profiling of asthma care? Med Care. 2008 Jun; 46(6):620-6. View abstract
  71. Staphylococcus aureus colonization among healthy children in Massachusetts in the post-PCV7 era. 2008 Pediatric Academic Societies’ Annual Meeting. 2008; Honolulu, Hawaii: Platform presentation. View abstract
  72. Clinician attitudes towards prescribing and implications for interventions in a multi-specialty group practice. J Eval Clin Pract. 2008 Dec; 14(6):969-73. View abstract
  73. Physician responses to a community-level trial promoting judicious antibiotic use. Ann Fam Med. 2008 May-Jun; 6(3):206-12. View abstract
  74. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf. 2008 May; 17(5):523-32. View abstract
  75. Research During Residency Training: Outcome & Resident Perspective of a PL-3 Block Rotation. 2008 Pediatric Academic Societies' Annual Meeting. 2008; Honolulu, Hawaii: Poster presentation. View abstract
  76. Secular trends in diagnosis and antibiotic treatment of childhood infections. HMO Research Network Conference. 2008; Poster presentation. View abstract
  77. Attorney General Consumer and Prescriber Grant Program. Changing Prescriber Behavior: Randomized Controlled Trial of Computerized Clinical Decision Support and Group Academic Detailing . HMO Research Network Conference. 2008; Poster presentation. View abstract
  78. Trends in otitis media treatment failure and relapse. Pediatrics. 2008 Apr; 121(4):674-9. View abstract
  79. Teaching population health as a basic science at Harvard Medical School. Acad Med. 2008 Apr; 83(4):332-7. View abstract
  80. Costs of Treatment of Crohn's Disease and Ulcerative Colitis in US Children and Adults. Gastroenterology. 2008; 134(4):A-155. View abstract
  81. Teaching population health as a basic science. Academic Medicine. 2008; 83(4):332-337. View abstract
  82. Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008 Jan; 121(1):e15-23. View abstract
  83. Are performance measures based on data extracted from automated medical record databases (including pharmacy, utilization and basic demographics) valid for physician/practice profiling asthma care. Medical Care. 2008; 46(6):620-626. View abstract
  84. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec; 5(12):1424-9. View abstract
  85. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis. 2007 Jul; 13(7):890-5. View abstract
  86. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Jun; 26(6):468-72. View abstract
  87. Virtual disappearance of pneumococcal vaccine strains from Massachusetts communities. Pediatric Academic Society Annual Meeting. 2007; (Late-breaker abstract; Platfo. View abstract
  88. Does connection to primary care matter for children with ADHD?. Pediatric Academic Society Annual Meeting. 2007; (Platform Session). View abstract
  89. Treatment and follow-up of children newly diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). Pediatric Academic Society Annual Meeting. 2007; (Platform Session). View abstract
  90. Length of stay and hospital charges for children with cystic fibrosis varies among freestanding children’s hospitals . Pediatric Academic Association. 2007; Poster Presentation. View abstract
  91. Clinician perceptions of pharmaceutical marketing and patient influences on prescribing. Society of General Internal Medicine. 2007; In press. . View abstract
  92. Parental knowledge about antibiotic use: results of a cluster-randomized, multicommunity intervention. Pediatrics. 2007 Apr; 119(4):698-706. View abstract
  93. Agreement between caregiver reported healthcare utilization and administrative data for children with asthma. J Asthma. 2007 Apr; 44(3):189-94. View abstract
  94. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis. 2007 Feb 01; 195(3):347-52. View abstract
  95. Planning for health promotion in low-income preschool child care settings: focus groups of parents and child care providers. Ambul Pediatr. 2006 Nov-Dec; 6(6):342-6. View abstract
  96. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf. 2006 Aug; 15(8):546-54. View abstract
  97. Unnecessary antibiotics. Virtual Mentor. 2006 Jun 01; 8(6):362-6. View abstract
  98. Results of REACH MAss: a 16-community trial to promote judicious antibiotic use. Platform presentation at the Pediatric Academic Societies Meeting, San Franciso. 2006. View abstract
  99. Physical and sedentary activity in child care centers. Poster presentation at the Pediatric Academic Societies Meeting, San Francisco. 2006. View abstract
  100. Parental perspectives on influenza vaccination among children with asthma. Public Health Rep. 2006 Mar-Apr; 121(2):181-8. View abstract
  101. Screening for type 2 diabetes mellitus in children and adolescents: attitudes, barriers, and practices among pediatric clinicians. Ambul Pediatr. 2006 Mar-Apr; 6(2):110-4. View abstract
  102. Predictors of hospital charges for children admitted with asthma. Ambul Pediatr. 2006 Jan-Feb; 6(1):15-20. View abstract
  103. Influenza vaccination among children with asthma in medicaid managed care. Ambul Pediatr. 2006 Jan-Feb; 6(1):1-7. View abstract
  104. Screening for Type 2 diabetes mellitus in children and adolescents: attitudes, barriers, and practices among pediatric clinicians. Ambulatory Pediatrics. 2006; 6:110-114. View abstract
  105. Unnecessary antibiotics http://www.ama-assn.org/ama/pub/category/16250.html. Virtual Mentor. 2006; 8:362-366. View abstract
  106. Post-PCV7 Expansion and Emergence of Sequence Types Among Serotype 19A and Serogroup 15 Streptococcus pneumoniae (SP) in Massachusetts Children 1999-2004 . 2006. View abstract
  107. Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team. Health Serv Res. 2005 Dec; 40(6 Pt 1):1737-57. View abstract
  108. Antibiotic treatment of children with sore throat. JAMA. 2005 Nov 09; 294(18):2315-22. View abstract
  109. Opportunities for health promotion education in child care. Pediatrics. 2005 Oct; 116(4):e499-505. View abstract
  110. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005 Sep; 116(3):e408-13. View abstract
  111. Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan. 2005 Sep; 20(5):302-9. View abstract
  112. Watchful waiting for acute otitis media: are parents and physicians ready? Pediatrics. 2005 Jun; 115(6):1466-73. View abstract
  113. Validity of the HEDIS criteria to identify children with persistent asthma and sustained high utilization. Am J Manag Care. 2005 May; 11(5):325-30. View abstract
  114. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Arch Pediatr Adolesc Med. 2005 May; 159(5):428-34. View abstract
  115. Effects of race, insurance status, and hospital volume on perforated appendicitis in children. Pediatrics. 2005 Apr; 115(4):920-5. View abstract
  116. Modeling community- and individual-level effects of child-care center attendance on pneumococcal carriage. Clin Infect Dis. 2005 May 01; 40(9):1215-22. View abstract
  117. Increased Carriage and emerging resistance of non-vaccine pneumococcal serotypes following universal immunization with PCV7. Pediatric Academic Societies Meeting, Washington, DC, May. 2005. View abstract
  118. Risk factors for missing influenza vaccination among medicaid-insured children with asthma. the Pediatric Academic Societies Meeting, Washington, DC, May. 2005. View abstract
  119. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics. 2004 Nov; 114(5):1206-11. View abstract
  120. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med. 2004 Sep; 158(9):875-83. View abstract
  121. Child care center policies and practices for management of ill children. Ambul Pediatr. 2004 Sep-Oct; 4(5):455-60. View abstract
  122. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004 Aug; 191(2):398-407. View abstract
  123. Antibiotic use in the first year of life and asthma in early childhood. Clin Exp Allergy. 2004 Jul; 34(7):1011-6. View abstract
  124. Cultural competence policies and other predictors of asthma care quality for Medicaid-insured children. Pediatrics. 2004 Jul; 114(1):e102-10. View abstract
  125. Pediatricians' self-reported clinical practices and adherence to national immunization guidelines after the introduction of pneumococcal conjugate vaccine. Arch Pediatr Adolesc Med. 2004 Jul; 158(7):695-701. View abstract
  126. Evaluation of asthma prescription measures and health system performance based on emergency department utilization. Med Care. 2004 May; 42(5):465-71. View abstract
  127. Community-level predictors of pneumococcal carriage and resistance in young children. Am J Epidemiol. 2004 Apr 01; 159(7):645-54. View abstract
  128. Diagnosis of acute appendicitis in children using a clinical practice guideline. J Pediatr Surg. 2004 Mar; 39(3):458-63; discussion 458-63. View abstract
  129. Use of asthma medication dispensing patterns to predict risk of adverse health outcomes: a study of Medicaid-insured children in managed care programs. Ann Allergy Asthma Immunol. 2004 Mar; 92(3):319-28. View abstract
  130. The effect of hospital volume of pediatric appendectomies on the misdiagnosis of appendicitis in children. Pediatrics. 2004 Jan; 113(1 Pt 1):18-23. View abstract
  131. Parental knowledge and attitudes on antibiotic use: results of a 16-community trial. Accepted for poster presentation at Pediatric Academic Societies Meeting. San Francisco,. 2004. View abstract
  132. Variability in asthma care and services for low-income populations among practice sites in managed Medicaid systems. Health Serv Res. 2003 Dec; 38(6 Pt 1):1563-78. View abstract
  133. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003 Oct; 112(4):862-9. View abstract
  134. Comparing asthma care provided to Medicaid-enrolled children in a Primary Care Case Manager plan and a staff model HMO. Ambul Pediatr. 2003 Sep-Oct; 3(5):253-62. View abstract
  135. Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol. 2003 Sep; 91(3):251-7. View abstract
  136. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003 Sep; 112(3 Pt 1):620-7. View abstract
  137. Correlates of parental antibiotic knowledge, demand, and reported use. Ambul Pediatr. 2003 Jul-Aug; 3(4):203-10. View abstract
  138. Acute care and antibiotic seeking for upper respiratory tract infections for children in day care: parental knowledge and day care center policies. Arch Pediatr Adolesc Med. 2003 Apr; 157(4):369-74. View abstract
  139. Misunderstanding of asthma controller medications: association with nonadherence. J Asthma. 2003 Feb; 40(1):17-25. View abstract
  140. Senior resident autonomy in a pediatric hospitalist system. Arch Pediatr Adolesc Med. 2003 Feb; 157(2):206-7. View abstract
  141. Asthma medication use and disease burden in children in a primary care population. Arch Pediatr Adolesc Med. 2003 Jan; 157(1):81-8. View abstract
  142. Effect of a pediatric hospitalist system on housestaff education and experience. Arch Pediatr Adolesc Med. 2002 Sep; 156(9):877-83. View abstract
  143. Pediatricians' views on financial barriers and values for pneumococcal vaccine for children. Ambul Pediatr. 2002 Sep-Oct; 2(5):358-66. View abstract
  144. Clinical effectiveness research in managed-care systems: lessons from the Pediatric Asthma Care PORT. Patient Outcomes Research Team. Health Serv Res. 2002 Jun; 37(3):775-89. View abstract
  145. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med. 2002 Jun; 156(6):562-7. View abstract
  146. Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics. 2002 May; 109(5):857-65. View abstract
  147. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002 Apr; 109(4):636-42. View abstract
  148. Process of care for Medicaid-enrolled children with asthma: served by community health centers and other providers. Med Care. 2002 Apr; 40(4):303-14. View abstract
  149. Parent-reported environmental exposures and environmental control measures for children with asthma. Arch Pediatr Adolesc Med. 2002 Mar; 156(3):258-64. View abstract
  150. Relationship between asthma medication and antibiotic use. Chest. 2001 Nov; 120(5):1485-92. View abstract
  151. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7. View abstract
  152. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001 Jul; 108(1):1-7. View abstract
  153. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001 Apr; 107(4):706-11. View abstract
  154. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med. 2001 Apr; 155(4):501-7. View abstract
  155. Asthma pharmacotherapy and utilization by children in 3 managed care organizations. The Pediatric Asthma Care Patient Outcomes Research Team. J Allergy Clin Immunol. 2000 Dec; 106(6):1108-14. View abstract
  156. Effect of a reduced postpartum length of stay program on primary care services use by mothers and infants. Pediatrics. 2000 Oct; 106(4 Suppl):937-41. View abstract
  157. Enrollees' perceptions of participating in the education of medical students at an academically affiliated HMO. Acad Med. 2000 Oct; 75(10):1003-9. View abstract
  158. Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics. 2000 Oct; 106(4 Suppl):886-96. View abstract
  159. Patient participation in research in the managed care environment: key perceptions of members in an HMO. J Gen Intern Med. 2000 Jul; 15(7):492-5. View abstract
  160. Comparing asthma care for Medicaid and non-Medicaid children in a health maintenance organization. Arch Pediatr Adolesc Med. 2000 Jun; 154(6):563-8. View abstract
  161. Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med. 2000 Apr; 154(4):395-400. View abstract
  162. Fever in pediatric primary care: occurrence, management, and outcomes. Pediatrics. 2000 Jan; 105(1 Pt 3):260-6. View abstract
  163. The impact of socioeconomic factors on asthma. In: Social and Economic Impacts of Asthma. Marcel Decker. New York. 2000; 219-243. View abstract
  164. The scope of unmet maternal health needs in pediatric settings. Pediatrics. 1999 Mar; 103(3):576-81. View abstract
  165. Managed care for children: defining the challenge. In: The Future of Children. David and Lucille Packard Foundation. 1999; 8:138-140. View abstract
  166. Pediatric education and managed care: a literature review. Pediatrics. 1998 Apr; 101(4 Pt 2):739-45. View abstract
  167. Pediatric residency training in an era of managed care: an introduction to proceedings of a national conference. Pediatrics. 1998 Apr; 101(4 Pt 2):735-8. View abstract
  168. Pediatric primary care follow-up after emergency department care. Ambulatory Child Health. 1996; 2:129-137. View abstract
  169. Quality of care for preschool children with asthma: the role of social factors and practice setting. Pediatrics. 1995 Mar; 95(3):389-94. View abstract
  170. Homeless children in America. Taking the next step. Am J Dis Child. 1993 May; 147(5):520-1. View abstract
  171. Homeless children in America: taking the next step. American Journal of Diseases of Children. 1993; 147:520-521. View abstract
  172. A survey of the health of homeless children in Philadelphia shelters. Am J Dis Child. 1991 May; 145(5):520-6. View abstract
  173. Common clinical features as predictors of bacterial diarrhea in infants. Am J Emerg Med. 1989 Sep; 7(5):469-73. View abstract